Seres Therapeutics, Inc.MCRBNASDAQ

Revenue (LTM)

$789000

Net Income (LTM)

$6M

+4088.2% YoY

Free Cash Flow

$865000

Revenue CAGR (5Y)

-72.8%

Marginsdeclining

FCFTurned positive

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	145	0	0	0	1
Gross Profit	145	0	0	-4	-3↑5.3%
Operating Income	-64	-180↓179.0%	-195↓8.4%	-121↑37.8%	-94↑22.5%
Net Income	-66	-250↓281.5%	-114↑54.5%	0↑100.1%	6↑4088.2%
EBITDA	-57	-171↓201.4%	-181↓6.1%	-120↑33.7%	-90↑25.3%
EPS Diluted	-14.30	-46.29↓223.7%	-17.77↑61.6%	-18.86↓6.1%	0.64↑103.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	180	163↓9.4%	128↓21.5%	31↓75.9%	46↑48.6%
Total Current Assets	304	195↓35.9%	175↓9.9%	39↓78.0%	49↑27.7%
Total Assets	355	349↓1.7%	359↑2.8%	140↓61.0%	138↓1.2%
Total Current Liabilities	82	86↑4.1%	99↑15.3%	41↓58.2%	19↓53.1%
Total Liabilities	223	338↑51.3%	403↑19.4%	126↓68.8%	94↓25.4%
Total Equity	132	11↓91.8%	-45↓516.0%	14↑130.7%	44↑220.8%
Total Debt	49	163↑230.4%	199↑22.3%	92↓53.9%	83↓9.5%
Net Debt	-131	-0↑99.7%	71↑16195.0%	61↓14.1%	37↓38.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	7	-229↓3521.3%	-117↑48.7%	-149↓26.6%	1↑100.8%
Capital Expenditure	-10	-10↓2.7%	-8↑18.8%	-0↑95.2%	-0↑33.7%
Free Cash Flow	-3	-239↓8191.8%	-125↑47.5%	-149↓18.9%	1↑100.6%
Stock-Based Comp	20	25↑26.0%	34↑33.8%	21↓38.5%	11↓48.3%
Net Change in Cash	72	-17↓123.3%	-35↓108.9%	-97↓175.7%	15↑115.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance